Lupin has acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million. The...

Lupin said it has inked a pact to acquire five drug brands from Italian firm Menarini for Rs 101 crore. The company has signed an agreement...

As a part of the transaction, Lupin's Australia subsidiary Generic Health will gain access to over 60 registered products having sales of o...

Generic Health, the Australia based wholly-owned subsidiary of Lupin, has entered into a definitive agreement under which Lupin will acquir...

Kyowa grew a modest 5% over the year-ago level. Its net profit halved to Rs 68.6 crore constituting 11.3% of Lupin’s consolidated profit. "...

The scrip touched its fresh 52-week high of Rs 1,572.25 on February 6, 2017 and its 52-week low of Rs 920 on August 21, 2017.

Lupin had entered into an arrangement to acquire the company earlier this year.

Lupin is looking at strengthening its branded portfolio by creating alliances and eyeing strategic brand acquisitions in US markets in 2015...

Mexico is one of the fastest growing pharmaceutical markets in the world valued at over $ 13.5 billion and growing at 9-10% annually.

Lupin Ltd is looking at strengthening branded portfolio with the launch of additional products developed and filed with the USFDA from its ...

Drug firm Lupin is targeting to double sales in Japan to $500 million (over Rs 2,600 crore) in the next five years on the back of enhanced ...

Lupin recently enhanced its presence in Japan with the acquisition of I'rom Pharmaceuticals in November this year for an undisclosed amount.

Drug maker Lupin is eyeing a jump of over 80 per cent in its revenues to $300 million (about Rs 1,557 crore) from the Japanese market in th...

Lupin Ltd. continues its buying spree with planned acquisitions in Gulf, Mexico, Brazil and Argentina.

Mumbai-based Lupin has been aggressively using the inorganic route to expand its cross-border generic business.

Drug maker Lupin plans to acquire a speciality pharmaceutical company in the United States to expand its portfolio of brands in the paediat...

Drug maker Lupin Ltd on Thursday said it has acquired the pharmaceutical business of Rubamin group, for an undisclosed amount.